Concepedia

Publication | Open Access

Comparative Efficacy of 177Lu and 90Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models

DOIFull Paper Access

36

Citations

39

References

2015

Year

Sofia H.L. Frost, Shani L. Frayo, Brian W. Miller, Johnnie J. Orozco, Garrett C. Booth, Mark D. Hylarides, Yukang Lin, Damian J. Green, Ajay K. Gopal, John M. Pagel,
PLoS ONE

Abstract

90Y was therapeutically superior to 177Lu for streptavidin-biotin PRIT approaches in these human lymphoma xenograft models.

References

YearCitations

Page 1